Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
L. Christiaens, P. Goeminne, L. Dupont (Leuven, Belgium). Achromobacter xylosoxidans: Friend or foe?. Eur Respir J 2011; 38: Suppl. 55, 4292

Member's Comments

No comment yet.

Related content which might interest you: Mycobacterium chelonei: friend or foe? Source: Eur Respir J 2007; 30: 397 Year: 2007 Bacterial colonisation in COPD: friend or foe? Source: Annual Congress 2010 - PG11 Postgraduate Course: Infection: a player in the natural history of COPD Year: 2010 Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania Source: Eur Respir J 2009; 33: 1216-1219 Year: 2009 Infection: friend or foe to the development of asthma? Source: Eur Respir J 2001; 18: 744-747 Year: 2001 Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated? Source: Eur Respir J 2011; 38: 1483-1486 Year: 2011 The "Coil Associated Opacity" in endoscopic emphysema treatment. Friend or foe? Source: International Congress 2018 – Endoscopic lung volume reduction Year: 2018 Cellular senescence: friend or foe to respiratory viral infections? Source: Eur Respir J, 56 (6) 2002708; 10.1183/13993003.02708-2020 Year: 2020 Achromobacter xylosoxidans in patients with primary ciliary dyskinesia Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Late Breaking Abstract - Biofilm formation by Pseudomonas aeruginosa in empyema Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty? Source: Eur Respir J 2010; 35: 473-474 Year: 2010 Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors? Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations Year: 2016 Chlamydia pneumoniae: crossing the barriers? Source: Eur Respir J 2004; 23: 499-500 Year: 2004 Pseudomonas Aeruginosa Infection in Respiratory Samples in Children with Neurodisability – to treat or not to treat? Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020 Asthma and Atypical Bacterial Infections: Chlamydia pneumonia, Mycoplasma pneumonia and Legionella pneumophila Source: Eur Respir J 2002; 20: Suppl. 38, 427s Year: 2002 Microbiology of non-CF bronchiectasis Source: Eur Respir Mon 2011; 52: 68-96 Year: 2011 Bronchiectasis and Stenotrophomonas maltophilia Source: Eur Respir J 2003; 22: Suppl. 45, 515s Year: 2003